Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection - Centre de Recherche en Transplantation et Immunologie
Article Dans Une Revue FASEB Journal Année : 2021

Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection

Résumé

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is an emerging respiratory pathogen that has rapidly spread in human populations. Severe forms of infection associate cytokine release syndrome and acute lung injury due to hyperinflammatory responses even though virus clearance is achieved. Key components of inflammation include immune cell recruitment in infected tissues, a step which is under the control of endothelial cells. Here, we review endothelial cell responses in inflammation and infection due to SARS-CoV-2 together with phenotypic and functional alterations of monocytes, T and B lymphocytes with which they interact. We surmise that endothelial cells function as an integrative and active platform for the various cells recruited, where fine tuning of immune responses takes place and which provides opportunities for therapeutic intervention.
Fichier principal
Vignette du fichier
main.pdf (606.41 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03391540 , version 1 (04-09-2024)

Identifiants

Citer

Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney. Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection. FASEB Journal, 2021, 35 (5), ⟨10.1096/fj.202100024R⟩. ⟨hal-03391540⟩
48 Consultations
11 Téléchargements

Altmetric

Partager

More